Back
Cara Therapeutics Vs. Cocrystal Pharma Industry Stock Comparison
Sell
17
CARA
Cara Therapeutics
Last Price:
0.31
Seasonality Move:
-5.78%
Sell
45
COCP
Cocrystal Pharma
Last Price:
1.77
Seasonality Move:
-15.53%
Sell
17
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy, Sell or Hold?
- The current Cara Therapeutics [CARA] share price is $0.31. The Score for CARA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- CARA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
Cocrystal Pharma (COCP)
is a Sell
Is Cocrystal Pharma a Buy, Sell or Hold?
- The current Cocrystal Pharma [COCP] share price is $1.77. The Score for COCP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- COCP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CARA Stock Price Chart
What is Cara Therapeutics's stock price today?
-
The Cara Therapeutics share price today is $0.31
The current trend is relatively stagnant and CARA is experiencing buying pressure, which is a positive indicator for future bullish movement.
COCP Stock Price Chart
What is Cocrystal Pharma's stock price today?
-
The Cocrystal Pharma share price today is $1.77
The current trend is relatively stagnant and COCP is experiencing slight selling pressure.
CARA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 48.11 | Sell |
| Chaikin Money Flow: | 226620 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.29 - 0.35) | Sell |
| Bollinger Bands (100): | (0.26 - 0.64) | Sell |
COCP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 48.01 | Sell |
| Chaikin Money Flow: | -3778 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.68 - 1.9) | Sell |
| Bollinger Bands (100): | (1.72 - 2.38) | Sell |
CARA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.28 | Buy |
| 20-day SMA: | 0.32 | Sell |
| 50-day SMA: | 0.34 | Sell |
| 200-day SMA: | 0.61 | Sell |
| 8-day EMA: | 0.29 | Buy |
| 20-day EMA: | 0.31 | Buy |
| 50-day EMA: | 0.35 | Sell |
| 200-day EMA: | 0.93 | Sell |
COCP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.71 | Buy |
| 20-day SMA: | 1.77 | Sell |
| 50-day SMA: | 1.92 | Sell |
| 200-day SMA: | 1.82 | Sell |
| 8-day EMA: | 1.73 | Buy |
| 20-day EMA: | 1.77 | Sell |
| 50-day EMA: | 1.88 | Sell |
| 200-day EMA: | 1.96 | Sell |
Cara Therapeutics Earnings Growth & CARA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.52 per share.
Cocrystal Pharma Earnings Growth & COCP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.15 per share, and a decrease next year of $0.27 per share.
Cara Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cocrystal Pharma Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||